Clinical manifestations of varicella-zoster virus infection (Q34743424)

4 August 2017

1 reference

title

Clinical manifestations of varicella-zoster virus infection (English)

1 reference

4 August 2017

T Minsue Chen

1

1 reference

4 August 2017

Saira George

series ordinal

2

1 reference

4 August 2017

Christy A Woodruff

series ordinal

3

1 reference

4 August 2017

Sylvia Hsu

series ordinal

4

1 reference

4 August 2017

publication date

1 April 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

20

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

267-282

1 reference

4 August 2017

cites work

Varicella zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Modification of chicken pox in family contacts by administration of gamma globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Herpesviridae. Definition, provisional nomenclature, and taxonomy. The Herpesvirus Study Group, the International Committee on Taxonomy of Viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Airborne transmission of chickenpox in a hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Detection of varicella-zoster virus DNA in air samples from hospital rooms

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Acyclovir treatment of varicella in otherwise healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Detection of varicella-zoster virus DNA in blood of children with varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Recent advances in varicella-zoster virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Selective decline in cellular immune response to varicella-zoster in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Viremia Caused by Varicella-Zoster Virus: Association with Malignant Progressive Varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Varicella causes skin pits and keloids--more reasons for the varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Photolocalized varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Immunization, abrasion, and sunburn as localizing factors in chicken pox

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Determination of immunity to varicella-zoster virus by means of an intradermal skin test

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Children hospitalized for varicella: a prevaccine review

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Varicella-zoster virus infections in children infected with human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Intrauterine viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Intrauterine Infection with Varicella-Zoster Virus after Maternal Varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Outcome after maternal varicella infection in the first 20 weeks of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Varicella-zoster virus infections in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Bacterial complications of primary varicella in children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

The Immunization Monitoring Program Active (IMPACT) prospective five year study of Canadian children hospitalized for chickenpox or an associated complication

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Streptococcal toxic shock-like syndrome as a complication of varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

CNS diseases associated with varicella zoster virus and herpes simplex virus infection. Pathogenesis and current therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Varicella mortality: trends before vaccine licensure in the United States, 1970-1994

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Varicella pneumonia in adults. A review of pulmonary manifestations, risk factors and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Hepatic cellular injury during varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Varicella Hepatitis: A Fatal Case in a Previously Healthy, Immunocompetent Adult

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Reye's syndrome in the United States from 1981 through 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Mechanisms of thrombocytopenia in varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Postinfectious purpura fulminans caused by an autoantibody directed against protein S

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Chronic verrucous varicella zoster virus skin lesions: clinical, histological, molecular and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Subclinical Varicella-Zoster Virus Viremia, Herpes Zoster, and T Lymphocyte Immunity to Varicella-Zoster Viral Antigens after Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

The varicella-zoster virus: Systemic and ocular features

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: community-based follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

RISK OF AIDS AFTER HERPES ZOSTER

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Herpes Zoster and Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Varicella-Zoster infection in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Disseminated ecthymatous herpes varicella-zoster virus infection in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Acyclovir resistant varicella zoster and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Hair follicle involvement in herpes zoster: pathway of viral spread from ganglia to skin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Low-productive alpha-herpesviridae infection in chronic lichenoid dermatoses

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Risk of Cancer after Herpes Zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Acyclovir for the prevention and treatment of varicella zoster in children, adolescents and pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Chronic verrucous varicella-zoster virus infection in patients with the acquired immunodeficiency syndrome (AIDS). Histologic and molecular biologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Acute monarticular arthritis in association with herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Esophageal stricture following esophagitis in a patient with herpes zoster: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Herpes zoster pericarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Gastric involvement in herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

1 reference

7 January 2021

Population-based study of herpes zoster and its sequelae

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Herpes Zoster: Epidemiology, Clinical Features, and Management

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Medical complications of herpes zoster in immunocompetent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Hypotheses on the pathogenesis of herpes zoster-associated pain

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

The progression of the ocular abnormalities of herpes zoster. Histopathologic observations of nine cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

The ocular manifestations of herpes zoster, varicella, infectious mononucleosis, and cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Association of varicella zoster dermatitis with acute retinal necrosis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Necrotizing fasciitis complicating disseminated cutaneous herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Skin disorders in black children.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Leukocytoclastic vasculitis associated with cutaneous infection by herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Fatal varicella in an immunocompromised adult

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

The Tzanck Smear: Old, but Still of Inestimable Value

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Routine detection of herpes simplex virus and varicella zoster virus by polymerase chain reaction reveals that initial herpes zoster is frequently misdiagnosed as herpes simplex

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Investigation of vesicular rashes for HSV and VZV by PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

A controlled trial of acyclovir for chickenpox in normal children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Intravenous acyclovir therapy for varicella in immunocompromised children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Acyclovir prevents dissemination of varicella in immunocompromised children.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Acyclovir therapy of chickenpox in immunosuppressed children--a collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Treatment of acute herpes zoster: effect of early (< 48 h) versus late (48-72 h) therapy with acyclovir and valaciclovir on prolonged pain

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Postherpetic neuralgia--pathogenesis, treatment, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Treatment of Ramsay Hunt syndrome with acyclovir-prednisone: significance of early diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Novel agents for the therapy of varicella-zoster virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Cost-effectiveness of a routine varicella vaccination program for US children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Varicella and zoster in children after kidney transplantation: long-term results of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Immunization of healthy adults with live attenuated varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Clinical trials of varicella vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Viral strain identification in varicella vaccinees with disseminated rashes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Risk factors for breakthrough varicella in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

1 reference

7 January 2021

Lasting immunity to varicella in doctors study (L.I.V.I.D. study)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Immunology of Varicella Immunization in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Live vaccine used to prevent the spread of varicella in children in hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

Postexposure varicella vaccination in siblings of children with active varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900012-2

7 January 2021

10.1016/S0733-8635(01)00012-2

Identifiers

DOI

1 reference

4 August 2017

1 reference